"L’institut Robert Merle d’Aubigné est un centre SSR spécialisé en Appareil Locomoteur et en Appareillage des Personnes Amputées. Etablissement privé non lucratif indépendant et à taille humaine, L’Institut est reconnu centre ressource en appareillage et en consolidation osseuse et centre de compétence pour l’appareillage des malformations de membres. Doté d’un atelier intégré d’appareillage, l’Institut réalise les prothèses d’entrainement et définitives et assure le suivi médicotechnique de grand appareillage en Ambulatoire. Chaque patient bénéficie d’une prise en charge pluridisciplinaire centrée sur un projet personnalisé de soins et a accès à un plateau technique complet incluant une piscine, un gymnase, un parc..."

During the past decade, Institut Robert Merle d'Aubigné conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Robert Merle d'Aubigné" #1 collaborator was "Pherecydes Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut Robert Merle d'Aubigné" are "Amputation of Hip and Thigh, Level Unspecified" (1 trials), "Diabetic Foot" (1 trials) and "Staphylococcal Infections" (1 trials). Many other conditions were trialed in "Institut Robert Merle d'Aubigné" in a lesser frequency.

Most popular intervention types in "Institut Robert Merle d'Aubigné" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "3C60-NMPK" (1 trials), "NMPK-3C60" (1 trials), "Topical anti-Staphylococcus bacteriophage therapy" (1 trials) and "Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Robert Merle d'Aubigné" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Robert Merle d'Aubigné". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut Robert Merle d'Aubigné, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Robert Merle d'Aubigné, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".